TERLIVAZ Trademark

Trademark Overview


On Tuesday, October 15, 2024, a trademark application was filed for TERLIVAZ with the United States Patent and Trademark Office. The USPTO has given the TERLIVAZ trademark a serial number of 98802165. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, April 23, 2025. This trademark is owned by Mallinckrodt Pharmaceuticals Ireland Limited. The TERLIVAZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hepatorenal syndrome (HRS).
terlivaz

General Information


Serial Number98802165
Word MarkTERLIVAZ
Filing DateTuesday, October 15, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, April 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of hepatorenal syndrome (HRS).

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 15, 2024
Primary Code005
First Use Anywhere DateThursday, December 20, 2012
First Use In Commerce DateWednesday, October 12, 2022

Trademark Owner History


Party NameMallinckrodt Pharmaceuticals Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin 15
IE

Trademark Events


Event DateEvent Description
Tuesday, October 15, 2024NEW APPLICATION ENTERED
Wednesday, April 16, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 23, 2025NON-FINAL ACTION E-MAILED
Wednesday, April 23, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 23, 2025NON-FINAL ACTION WRITTEN
Thursday, April 17, 2025ASSIGNED TO EXAMINER